GlassScriptPhysician profile
Anel Iveth Marquez
NPI 1295498251
$2,408.18
in general payments reported to CMS, 2019-2025
24 companies · $950 in 2025
The $950 reported for 2025 was more than what 86% of Primary Care providers received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $130 · 2023: $659 · 2024: $669 · 2025: $950.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,063 · Education: $215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,063.00 |
| Education | $214.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $511.18 | 2022-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Astrazeneca Pharmaceuticals LP | $417.26 | 2023-2025 | Fasenra, Tezspire, Airsupra |
| Mylan Specialty L.P. | $142.54 | 2022-2024 | Yupelri |
| Insmed, INC. | $133.84 | 2023-2025 | Arikayce |
| Philips North America LLC | $129.19 | 2023-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| United Therapeutics Corporation | $122.67 | 2022-2025 | Tyvaso, Tyvaso |
| Boehringer Ingelheim Pharmaceuticals, INC. | $122.25 | 2023-2025 | Ofev, Jascayd |
| Amgen INC. | $116.86 | 2023-2025 | Tezspire |
| Sanofi-Aventis U.S. LLC | $99.99 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $96.97 | 2023-2025 | Dupixent |
| Baxter Healthcare | $63.94 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System, Hillrom - Monarch Airway Clearance System |
| Grifols USA, LLC | $59.18 | 2025 | Prolastin-C Liquid |
| Viatris Specialty LLC | $49.66 | 2025 | Yupelri |
| Novartis Pharmaceuticals Corporation | $42.57 | 2023-2024 | |
| Paratek Pharmaceuticals, INC. | $39.55 | 2025 | Nuzyra, Xhance |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $39.19 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Genzyme Corporation | $35.52 | 2025 | |
| Lilly USA, LLC | $35.12 | 2025 | Zepbound |
| Boston Scientific Corporation | $31.04 | 2022 | |
| Verona Pharma, INC. | $30.06 | 2025 | Ohtuvayre |
| Ethicon INC. | $29.56 | 2022 | |
| Ani Pharmaceuticals, INC. | $29.55 | 2025 | Purified Cortrophin Gel |
| Inogen, INC. | $16.80 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.69 | 2025 | Glassia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anel Marquez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.